Clinically relevant changes in emotional expression in children with ADHD treated with lisdexamfetamine dimesylate.
about
Update on optimal use of lisdexamfetamine in the treatment of ADHD.Treatment outcomes with lisdexamfetamine dimesylate in children who have attention-deficit/hyperactivity disorder with emotional control impairments.Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder.Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy.The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial.
P2860
Clinically relevant changes in emotional expression in children with ADHD treated with lisdexamfetamine dimesylate.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Clinically relevant changes in ...... h lisdexamfetamine dimesylate.
@en
Clinically relevant changes in ...... h lisdexamfetamine dimesylate.
@nl
type
label
Clinically relevant changes in ...... h lisdexamfetamine dimesylate.
@en
Clinically relevant changes in ...... h lisdexamfetamine dimesylate.
@nl
prefLabel
Clinically relevant changes in ...... h lisdexamfetamine dimesylate.
@en
Clinically relevant changes in ...... h lisdexamfetamine dimesylate.
@nl
P2093
P2860
P356
P1476
Clinically relevant changes in ...... h lisdexamfetamine dimesylate.
@en
P2093
Alain Katic
Atilla Turgay
Brian Scheckner
Bryan Dirks
Cynthia Richards
Lawrence Ginsberg
Rakesh Jain
Robert L Findling
Robert Lasser
P2860
P304
P356
10.1177/1087054710389990
P577
2010-12-20T00:00:00Z